96 related articles for article (PubMed ID: 26986108)
1. Haploidentical Transplantation Without In Vitro T-Cell Depletion Results in Outcomes Equivalent to Those of Contemporaneous Matched Sibling and Unrelated Donor Transplantation for Acute Leukemia.
Yu S; Fan Q; Sun J; Fan Z; Zhang Y; Jiang Q; Huang F; Xuan L; Dai M; Zhou H; Liu H; Liu QF
Medicine (Baltimore); 2016 Mar; 95(11):e2973. PubMed ID: 26986108
[TBL] [Abstract][Full Text] [Related]
2. Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT.
Sanz J; Galimard JE; Labopin M; Afanasyev B; Sergeevich MI; Angelucci E; Kröger N; Koc Y; Ciceri F; Diez-Martin JL; Arat M; Sica S; Rovira M; Aljurf M; Tischer J; Savani B; Ruggeri A; Nagler A; Mohty M
J Hematol Oncol; 2021 May; 14(1):84. PubMed ID: 34049582
[TBL] [Abstract][Full Text] [Related]
3. Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Pereira MP; Remberger M; Chen C; Gerbitz A; Kim DDH; Kumar R; Lam W; Law AD; Lipton JH; Michelis FV; Novitzky-Basso I; Viswabandya A; Mattsson J; Pasic I
Transplant Cell Ther; 2023 Nov; 29(11):697.e1-697.e10. PubMed ID: 37579919
[TBL] [Abstract][Full Text] [Related]
4. Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.
Saad A; Lamb L; Wang T; Hemmer MT; Spellman S; Couriel D; Alousi A; Pidala J; Abdel-Azim H; Agrawal V; Aljurf M; Beitinjaneh AM; Bhatt VR; Buchbinder D; Byrne M; Cahn JY; Cairo M; Castillo P; Chhabra S; Diaz MA; Farhan S; Floisand Y; Frangoul HA; Gadalla SM; Gajewski J; Gale RP; Gandhi M; Gergis U; Hamilton BK; Hematti P; Hildebrandt GC; Kamble RT; Kanate AS; Khandelwal P; Lazaryan A; MacMillan M; Marks DI; Martino R; Mehta PA; Nishihori T; Olsson RF; Patel SS; Qayed M; Rangarajan HG; Reshef R; Ringden O; Savani BN; Schouten HC; Schultz KR; Seo S; Shaffer BC; Solh M; Teshima T; Urbano-Ispizua A; Verdonck LF; Vij R; Waller EK; William B; Wirk B; Yared JA; Yu LC; Arora M; Hashmi S
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1875-1883. PubMed ID: 31085303
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission Status.
Konuma T; Yamasaki S; Ishiyama K; Mizuno S; Hayashi H; Uchida N; Shimabukuro M; Tanaka M; Kuriyama T; Onizuka M; Ishiwata K; Sawa M; Tanaka T; Ohigashi H; Fujiwara SI; Matsuoka KI; Ota S; Nishida T; Kanda Y; Fukuda T; Atsuta Y; Nakasone H; Yanada M;
Transplant Cell Ther; 2024 Feb; 30(2):215.e1-215.e18. PubMed ID: 38081415
[TBL] [Abstract][Full Text] [Related]
6. Haploidentical and Matched Sibling Transplantation for Acute Myeloid Leukemia: A Hospital-Based Study.
Baena JC; Rosales MC; Estacio M; Hidalgo A; Arrieta E; Jaramillo FJ; Manzi E; Parra-Lara LG; Rosales JD
J Hematol; 2023 Dec; 12(6):255-267. PubMed ID: 38188474
[TBL] [Abstract][Full Text] [Related]
7. Donor matters: Donor selection impact on hematopoietic stem cell transplantation outcomes in Hispanic patients with B-cell acute lymphocytic leukemia: Insights from a myeloablative HSCT study.
Ashouri K; Ginosyan AA; Chu M; Hom B; Hwang J; Resnick K; Rahimi Y; Chaudhary P; Woan K; Siddiqi I; Ladha A; Ali A; Tam EL; Yaghmour G
Leuk Res; 2024 Jun; 141():107501. PubMed ID: 38631149
[TBL] [Abstract][Full Text] [Related]
8. Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.
Marks DI; Pérez WS; He W; Zhang MJ; Bishop MR; Bolwell BJ; Bredeson CN; Copelan EA; Gale RP; Gupta V; Hale GA; Isola LM; Jakubowski AA; Keating A; Klumpp TR; Lazarus HM; Liesveld JL; Maziarz RT; McCarthy PL; Sabloff M; Schiller G; Sierra J; Tallman MS; Waller EK; Wiernik PH; Weisdorf DJ
Blood; 2008 Jul; 112(2):426-34. PubMed ID: 18398065
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplant: A two-decade single centre hematology experience.
Kumar R; Kapoor R; Sharma S; Pramanik SK; Yanamandra U; Mishra K; Khera S; Sharma A; Das S; Verma T; Singh J; Nair V
Med J Armed Forces India; 2023; 79(6):657-664. PubMed ID: 37981920
[TBL] [Abstract][Full Text] [Related]
10. Pick Your Poison: Higher Risk of Relapse (older MSD) or A Higher Risk of Non-Relapse Mortality (younger MUD)?
Mehta RS
Transplant Cell Ther; 2023 Oct; 29(10):587-588. PubMed ID: 37827596
[No Abstract] [Full Text] [Related]
11. Autoimmune hematological diseases following haploidentical donor hematopoietic stem cell Transplant compared with matched sibling and unrelated donor.
Lv W; Fan Z; Huang F; Xu N; Xuan L; GuopanYu ; Jiang Q; Zhou H; Lin R; Zhang X; Sun J; Liu Q
Oncotarget; 2017 Apr; 8(16):26505-26514. PubMed ID: 28460445
[TBL] [Abstract][Full Text] [Related]
12. Case Series Using Salvage Haplo-Identical Stem Cells for Secondary Transplantation.
Ionete A; Varady Z; Szegedi O; Coriu D
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374281
[TBL] [Abstract][Full Text] [Related]
13. How to improve the outcomes of elderly acute myeloid leukemia patients through allogeneic hematopoietic stem cell transplantation.
Jiang S; Yan H; Lu X; Wei R; Chen H; Zhang A; Shi W; Xia L
Front Immunol; 2023; 14():1102966. PubMed ID: 37207218
[TBL] [Abstract][Full Text] [Related]
14. Effect of pediatric- versus adult-type chemotherapy regimens on outcomes of allogeneic hematopoietic stem cell transplants for adult T-cell acute lymphoblastic leukemia in first complete remission.
Qi HZ; Xu J; Yang QQ; Lin R; Wang ZX; Zhao K; Wang Q; Zhou X; Fan ZP; Huang F; Xu N; Xuan L; Jin H; Sun J; Gale RP; Zhou HS; Liu QF
Bone Marrow Transplant; 2022 Nov; 57(11):1704-1711. PubMed ID: 36042299
[TBL] [Abstract][Full Text] [Related]
15. Haploidentical donor transplant is associated with secondary poor graft function after allogeneic stem cell transplantation: A single-center retrospective study.
Lv WR; Zhou Y; Xu J; Fan ZP; Huang F; Xu N; Xuan L; Shi PC; Liu H; Wang ZX; Sun J; Liu QF
Cancer Med; 2021 Dec; 10(23):8497-8506. PubMed ID: 34668661
[TBL] [Abstract][Full Text] [Related]
16. Association Between Measurable Residual Disease in Patients With Intermediate-Risk Acute Myeloid Leukemia and First Remission, Treatment, and Outcomes.
Yu S; Fan Z; Ma L; Wang Y; Huang F; Zhang Q; Huang J; Wang S; Xu N; Xuan L; Xiong M; Han L; Sun Z; Zhang H; Liu H; Yu G; Shi P; Xu J; Wu M; Guo Z; Xiong Y; Duan C; Sun J; Liu Q; Zhang Y
JAMA Netw Open; 2021 Jul; 4(7):e2115991. PubMed ID: 34232303
[TBL] [Abstract][Full Text] [Related]
17. Myeloablative Haploidentical Transplant as an Alternative to Matched Sibling Transplant for Peripheral T-Cell Lymphomas.
Zhenyang G; Nainong L; Xiaoxiong W; Maihong W; Xiaorui F; Zhao W; Hanyun R; Yuhang L; Xiaofan L; Yamei W; Yao L; Mingzhi Z; Yini W; Daihong L; Yujun D; Liangding H; Wenrong H
Cell Transplant; 2021; 30():963689721999615. PubMed ID: 33745341
[TBL] [Abstract][Full Text] [Related]
18. Anti-Ro52 Autoantibodies Are Related to Chronic Graft-vs.-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Yang K; Chen Y; Qi H; Ye Y; Fan Z; Huang F; Zhang H; Suo Y; Liu Q; Jin H
Front Immunol; 2020; 11():1505. PubMed ID: 32849514
[TBL] [Abstract][Full Text] [Related]
19. Haploidentical related donor vs matched sibling donor allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome aged over 50 years: A single-center retrospective study.
Huang J; Huang F; Fan Z; Xu N; Xuan L; Liu H; Shi P; Jiang L; Zhang Y; Sun J; Liu Q
Cancer Med; 2020 Sep; 9(17):6244-6255. PubMed ID: 32686915
[TBL] [Abstract][Full Text] [Related]
20. Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data.
Yu S; Huang F; Fan Z; Xuan L; Nie D; Xu Y; Yang T; Wang S; Jiang Z; Xu N; Lin R; Ye J; Lin D; Sun J; Huang X; Wang Y; Liu Q
J Hematol Oncol; 2020 Mar; 13(1):18. PubMed ID: 32164760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
